Irritable Bowel Syndrome Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type
Condition: Irritable Bowel Syndrome of Diarrhea Type (IBS-D) Interventions: Drug: OPS-2071; Drug: placebo Sponsor: Otsuka Beijing Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials
